Phio Pharmaceuticals Corp. Total Non Current Liabilities 2011-2026 | PHIO

Annual Total Non Current Liabilities Phio Pharmaceuticals Corp.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	526 K	411 K	-	-	-	-	5.11 M	7.92 M	9.75 M	505 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9.75 M	411 K	4.04 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	326 M	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
ADMA Biologics ADMA	99.5 M	$ 15.36	-2.17 %	$ 3.66 B	USA
Cellectis S.A. CLLS	109 M	$ 3.53	-3.54 %	$ 116 M	France
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	289 M	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Nymox Pharmaceutical Corporation NYMX	368 K	-	-19.68 %	$ 18.4 M	Canada
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	2.21 M	$ 0.79	-1.15 %	$ 4.31 M	China
Autolus Therapeutics plc AUTL	50.6 M	$ 1.51	1.35 %	$ 385 M	Britain
China SXT Pharmaceuticals SXTC	212 K	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	44 K	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Anika Therapeutics ANIK	26.1 M	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	182 M	$ 74.36	-1.64 %	$ 1.44 B	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	14.7 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	48.9 M	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	44.7 M	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	97.6 M	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
BioLineRx Ltd. BLRX	8.22 M	$ 2.69	-0.74 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	635 M	$ 61.3	1.21 %	$ 11.8 B	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA